FDA Adverse Event Malfunction Summary report: N

ACCESS® 2 IMMUNOASSAY SYSTEM

MDR report key: 1972163 · Received January 27, 2011

Report

Report Number
2122870-2011-00155
Event Type
Malfunction
Date Received
January 27, 2011
Date of Event
December 30, 2010
Report Date
December 30, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K922823/A007
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A SYSTEM CHECK WAS PERFORMED ON (B)(4) 2010 AND MET SPECIFICATIONS. THE CUSTOMER CONTACTED CUSTOMER TECHNICAL SUPPORT AND ALSO MENTIONED THAT THE SYSTEM WAS GENERATING REAGENT CAROUSEL MOTION ERRORS WHILE LOADING A NEW ACCUTNI REAGENT PACK ON TO THE INSTRUMENT. CTS HAD THE CUSTOMER UNLOAD THE ACCUTNI REAGENT. THE CUSTOMER FOUND THAT THE REAGENT PACK WAS MISLOADED AND THEREFORE IN THE INCORRECT SLOT OF THE REAGENT STORAGE CAROUSEL. WHEN THIS OCCURS THE INSTRUMENT DOES NOT DETECT EITHER A WRONG REAGENT PACK OR NO REAGENT PACK PRESENT. THE CUSTOMER REMOVED THE MISLOADED REAGENT PACK, DELETED THE PACK FROM THE REAGENT INVENTORY, AND DISCARDED IT. USER ERROR IS THE ROOT CAUSE OF THIS EVENT.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) IN REGARDS TO OBTAINING NO VALUE RESULTS WITH INDETERMINANT (IND) FLAGS FOR TWO PATIENTS' SAMPLES WHEN BEING ANALYZED FOR TROPONIN (ACCUTNI) ON THE ACCESS 2 IMMUNOASSAY SYSTEM. REPEAT TESTING ON AN ALTERNATE INSTRUMENT RESULTED WITH ONE PATIENT IN THE NORMAL REFERENCE RANGE AND THE SECOND PATIENT RESULTING IN THE RISK STRATIFICATION RANGE. THE CUSTOMER DID NOT RECEIVE ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACCESS® 2 IMMUNOASSAY SYSTEM DISCRETE PHOTOMETRIC CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. ACCESS 2 N/A

Patients

Seq Age Sex Outcome Treatment
1